0001127602-24-005073.txt : 20240214 0001127602-24-005073.hdr.sgml : 20240214 20240214171441 ACCESSION NUMBER: 0001127602-24-005073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Havanec Laurie P. CENTRAL INDEX KEY: 0001807757 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 24640521 MAIL ADDRESS: STREET 1: ONE CARRIER PLACE CITY: FARMINGTON STATE: CT ZIP: 06032 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-02-12 0000064803 CVS HEALTH Corp CVS 0001807757 Havanec Laurie P. ONE CVS DRIVE WOONSOCKET RI 02895 1 EVP and Chief People Officer 0 Common Stock 2024-02-12 4 A 0 16817 0 A 37203 D Common Stock (Restricted) 14678 D Stock Option 74.30 2022-04-01 2031-04-01 Common Stock 27643 27643 D Stock Option 101.09 2023-04-01 2032-04-01 Common Stock 21829 21829 D Stock Option 74.31 2024-04-01 2033-04-01 Common Stock 51959 51959 D Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Option became exercisable in four equal installments, commencing 4/1/2022. Option became exercisable in four equal installments, commencing 4/1/2023. Option becomes exercisable in four equal installments, commencing 4/1/2024. /s/ Laurie P. Havanec 2024-02-13